Skip to main content
Top
Published in: Annals of Hematology 5/2005

01-05-2005 | Original Article

High prevalence of Helicobacter pylori infection and monoclonal gammopathy of undetermined significance in patients with chronic idiopathic neutropenia

Authors: Helen A. Papadaki, Charalambos Pontikoglou, Emily Stavroulaki, George Minadakis, Dimitrios A. Eliopoulos, Katerina Pyrovolaki, Panagiotis Skordilis, George D. Eliopoulos

Published in: Annals of Hematology | Issue 5/2005

Login to get access

Abstract

The prevalence of Helicobacter pylori infection was evaluated in 120 patients with chronic idiopathic neutropenia (CIN), 8 patients with monoclonal gammopathy of undetermined significance (MGUS) associated with CIN, and 74 age- and sex-matched normal volunteers, all derived from the same geographical area. The purpose of the study was to investigate the possible causal relationships of H. pylori infection with the development of MGUS in CIN patients. We found that the prevalence of H. pylori infection was elevated to 69.2% in the group of CIN patients, 100% in the group of patients with CIN-associated MGUS, and 32.4% in the group of control subjects. No statistically significant difference, however, was found in the prevalence of H. pylori infection between CIN patients with concomitant MGUS and CIN patients without MGUS, no resolution of the gammopathy after eradication of the bacterium, no significant rise in the titers of serum anti-H. pylori antibodies, and no formation of an abnormal precipitation line in immunoelectrophoresis using a saline extract of NCTC11367 H. pylori reference strain as antigen. We concluded that there is no evidence that H. pylori infection is the cause of MGUS in CIN patients.
Literature
1.
go back to reference Blaser MJ (1990) Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161:626–633 Blaser MJ (1990) Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161:626–633
2.
go back to reference Hentschel E, Brandstatter G, Dragosics AM, Hirschl AM, Nemec H, Schutze K, Taufer M, Wurzer H (1993) Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328:308–312 Hentschel E, Brandstatter G, Dragosics AM, Hirschl AM, Nemec H, Schutze K, Taufer M, Wurzer H (1993) Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 328:308–312
3.
go back to reference Kyle RA, Rajkumar SV (1999) Monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North Am 13:1181–1202PubMed Kyle RA, Rajkumar SV (1999) Monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North Am 13:1181–1202PubMed
4.
go back to reference Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ (2002) A long-term study of prognosis of monoclonal gammopathy of undetermined significance. N Engl J Med 346:564–569CrossRefPubMed Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ (2002) A long-term study of prognosis of monoclonal gammopathy of undetermined significance. N Engl J Med 346:564–569CrossRefPubMed
5.
go back to reference Malik AA, Ganti AK, Potti A, Levitt R, Hanley JF (2002) Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance. Am J Gastroenterol 97:1371–1374 Malik AA, Ganti AK, Potti A, Levitt R, Hanley JF (2002) Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance. Am J Gastroenterol 97:1371–1374
6.
go back to reference Nakamura S, Aoyagi K, Furuse M, Suekane H, Matsumoto T, Yao T, Sakai Y, Fuchigami T, Yamamoto I, Tsuneyoshi M, Fujishima M (1998) B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 152:1271–1279 Nakamura S, Aoyagi K, Furuse M, Suekane H, Matsumoto T, Yao T, Sakai Y, Fuchigami T, Yamamoto I, Tsuneyoshi M, Fujishima M (1998) B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 152:1271–1279
7.
go back to reference Papadaki HA, Eliopoulos AG, Kosteas T, Gemetzi C, Damianaki A, Koutala H, Bux J, Eliopoulos GD (2003) Impaired granulocytopoiesis in chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood 101:2591–2600CrossRefPubMed Papadaki HA, Eliopoulos AG, Kosteas T, Gemetzi C, Damianaki A, Koutala H, Bux J, Eliopoulos GD (2003) Impaired granulocytopoiesis in chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood 101:2591–2600CrossRefPubMed
8.
go back to reference Papadaki HA, Eliopoulos DG, Pontikoglou C, Eliopoulos GD (2001) Increased frequency of monoclonal gammopathy of undetermined significance in patients with nonimmune chronic idiopathic neutropenia of adult. Int J Hematol 73:339–345 Papadaki HA, Eliopoulos DG, Pontikoglou C, Eliopoulos GD (2001) Increased frequency of monoclonal gammopathy of undetermined significance in patients with nonimmune chronic idiopathic neutropenia of adult. Int J Hematol 73:339–345
9.
go back to reference Papadaki HA, Eliopoulos GD (1998) Enhanced neutrophil extravasation may be a contributing factor in the determination of neutropenia in patients with chronic idiopathic neutropenia of adults. Eur J Haematol 61:272–277 Papadaki HA, Eliopoulos GD (1998) Enhanced neutrophil extravasation may be a contributing factor in the determination of neutropenia in patients with chronic idiopathic neutropenia of adults. Eur J Haematol 61:272–277
10.
go back to reference Papadaki HA, Palmblad J, Eliopoulos GD (2001) Non-immune chronic idiopathic neutropenia of adult: an overview. Eur J Haematol 67:35–44 Papadaki HA, Palmblad J, Eliopoulos GD (2001) Non-immune chronic idiopathic neutropenia of adult: an overview. Eur J Haematol 67:35–44
11.
go back to reference Parsonnet J, Freedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMed Parsonnet J, Freedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131PubMed
12.
go back to reference Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orientzeich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267–1271CrossRefPubMed Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orientzeich N, Vogelman JH, Friedman GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267–1271CrossRefPubMed
13.
go back to reference Peek RM Jr, Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev 2:28–37CrossRefPubMed Peek RM Jr, Blaser MJ (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev 2:28–37CrossRefPubMed
14.
go back to reference Rajkumar SV, Kyle RA, Plevak MF, Murray JA, Therneau TM (2002) Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol 119:706–708 Rajkumar SV, Kyle RA, Plevak MF, Murray JA, Therneau TM (2002) Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol 119:706–708
15.
go back to reference Uemura N (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789CrossRefPubMed Uemura N (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784–789CrossRefPubMed
Metadata
Title
High prevalence of Helicobacter pylori infection and monoclonal gammopathy of undetermined significance in patients with chronic idiopathic neutropenia
Authors
Helen A. Papadaki
Charalambos Pontikoglou
Emily Stavroulaki
George Minadakis
Dimitrios A. Eliopoulos
Katerina Pyrovolaki
Panagiotis Skordilis
George D. Eliopoulos
Publication date
01-05-2005
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 5/2005
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-004-0996-y

Other articles of this Issue 5/2005

Annals of Hematology 5/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine